BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance

SIMPLE SUMMARY: BCL2L10 is the sixth and less studied protein from the group of Bcl-2 anti-apoptotic proteins. These proteins are important therapeutic targets since they convey resistance to anticancer regimens. We describe here for the first time the role of BCL2L10 in melanoma. We found that BCL2...

Descripción completa

Detalles Bibliográficos
Autores principales: Quezada, María Josefina, Picco, María Elisa, Villanueva, María Belén, Castro, María Victoria, Barbero, Gastón, Fernández, Natalia Brenda, Illescas, Edith, Lopez-Bergami, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795116/
https://www.ncbi.nlm.nih.gov/pubmed/33396645
http://dx.doi.org/10.3390/cancers13010078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795116/
https://www.ncbi.nlm.nih.gov/pubmed/33396645
http://dx.doi.org/10.3390/cancers13010078

Ejemplares similares